We investigated whether Deuterium Metabolic Imaging (DMI) with 2H-labeled glucose can be used to monitor treatment response in a pre-clinical murine lymphoma model (EL4). Localized 2H spectra were acquired from tumors, with a time resolution of ~1min, following a bolus injection of labeled glucose. These showed inhibition of lactate labeling following treatment of the tumors with etoposide. 2D chemical shift images (2D CSI) were acquired from the tumors, but imaging treatment response may need faster image acquisition. Studies with a respiratory chain inhibitor in vitro suggested that labeling of water in EL4 tumor cells may be due, at least in part, to TCA cycle activity.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords